# Feature 011 delegated technical closeout

Date: 2026-10-10. **Engineering evidence is ready for K24 review. Formal acceptance remains blocked by the retained owner/profile gates.** The primary agent owns this judgment under Yousef Osama's explicit technical/operational delegation. No checkpoint acceptance, role appointment, gate closure or Git integration is inferred.

[Root review](root-review.json), [repeat results](performance-repeat-summary.json) and [reproducibility profile](reproducibility-profile.md) bind the current proof. Three complete serial repeats passed on both PostgreSQL 17.11 and Supabase PostgreSQL 17.6: 42 independently recomputed operation/runtime p95 checks, 960 measured requests, 144 warmup requests and no threshold misses. All 12 harness-owned temporary databases were dropped with absence verified, without forced cleanup or shared reset. External-under-lock counters were zero throughout.

| Runtime | Operation | Repeat p95 range (ms) | Limit (ms) | Result |
| --- | --- | ---: | ---: | --- |
| shifaa-local-postgres | createAllergy | 70.23–79.16 | 800 | 3/3 PASS |
| shifaa-local-postgres | verifyAllergy | 298.29–319.86 | 800 | 3/3 PASS |
| shifaa-local-postgres | listAllergies | 120.90–128.74 | 400 | 3/3 PASS |
| shifaa-local-postgres | createClinicalContentRelease | 100.36–140.13 | 800 | 3/3 PASS |
| shifaa-local-postgres | signClinicalContentRelease | 264.45–343.98 | 800 | 3/3 PASS |
| shifaa-local-postgres | publishClinicalContentRelease | 177.11–229.19 | 800 | 3/3 PASS |
| shifaa-local-postgres | listClinicalContent | 34.26–62.77 | 400 | 3/3 PASS |
| shifaa-local-supabase | createAllergy | 72.13–80.81 | 800 | 3/3 PASS |
| shifaa-local-supabase | verifyAllergy | 293.54–308.52 | 800 | 3/3 PASS |
| shifaa-local-supabase | listAllergies | 119.53–120.66 | 400 | 3/3 PASS |
| shifaa-local-supabase | createClinicalContentRelease | 87.59–94.40 | 800 | 3/3 PASS |
| shifaa-local-supabase | signClinicalContentRelease | 239.33–320.57 | 800 | 3/3 PASS |
| shifaa-local-supabase | publishClinicalContentRelease | 170.20–185.42 | 800 | 3/3 PASS |
| shifaa-local-supabase | listClinicalContent | 32.09–38.87 | 400 | 3/3 PASS |

The workload remains serial, completion-driven, Fastify injection through native Auth loopback and a non-owner DB pool. Owner-only synthetic control overhead inside a timed request remains included. Unset Docker quotas/shared host resources, concurrency above one, representative deployment datasets, WAN/mobile rendering and production vendor timing are outside this result. The three-run procedure strengthens local repeatability only; it is not production SLO/DR or formal reference-environment acceptance. Raw samples, all three logs, exact executed source copies and original hashes are retained. The executed copies differ only by import location and evidence destination. The original runner and accepted K23 proof are preserved.

[Current parity](current-parity.json) and the final root validation confirm 141 current pins, current contract/client generation and unchanged SQL/core/protection/evidence contracts. Today's existing pnpm verify execution exited zero; its proof, full log and all 141 source bindings were freshly checked. There has been no implementation change warranting a repeat of that full run. The prior engineering packet's eight file references remain byte-identical.

[Independent UI second pass](ux-review.md) inspected 12 hash-matching saved images across four routes, AR/EN and compact/wide, with no confirmed product defect. This is a selected-image review, not a manual pass of all 99 states/746 references. Tall/cropped images, generic transport-state labels and absent capture-time component pins remain explicit evidence limitations. Physical NVDA/TalkBack testing remains attributed to the user's no-issue reports; no speech transcripts, display settings or per-state execution details are invented. The new profile's stale device-version unknowns were corrected against the existing version record and reviewer consolidation. Historical evidence was not rewritten.

T088 has browser engineering coverage plus the attributed physical review; T089 approved documentation maintenance, T090 parity and T091 full verification remain green within their stated engineering boundaries. T092's prior authorized owner-disposition requests remain recorded; this packet supplements their evidence without asserting formal closure. T088–T092 remain unchecked and Issues #485–#489 remain open, freshly read from GitHub.

The remaining formal decisions are concrete: identify the accountable Feature 011 QA Lead, Platform Lead and formal Design Lead; then approve the applicable bounded reference configuration and review corresponding evidence. [Visual proposal](visual-reference-proposal.md) supplies a proposed deterministic matrix, zero changed-pixel/channel tolerance, no masks and recorded human diff review. This is a proposed replaceable functional baseline, not an executed comparison or permanent style lock. It has not been silently adopted as an approved requirement. The observed Chrome/font sources and current physical device versions are bound; actual renderer/build/font assets, native settings and the approved baseline execution still need formal recording. [Server profile](reproducibility-profile.md) specifies the exact completed local workload; a deployed/device/network profile is not inferred.

The authority is the unchanged Master OPEN-UX-002 row (Product Owner + Design Lead + QA Lead; deterministic renderer, numeric thresholds, masks and review evidence) and OPEN-TECH-003 row (QA Lead + Platform Lead + Product Owner; approved reproducible profiles/configs/baseline). Delegated technical work cannot invent those human appointments or dispositions.

No product/SQL/schema/grant/contract change, no Feature 012 work, no clinical/KMS/production/final-design claim, and no commit/push/PR/main change. Branch remains codex/011-allergies-clinical-content-governance; HEAD and local main remain 670b1e0fe15c719b98179805f2628d1b478a55dd. Git status retains 170 inherited entries; [exact status](git-status.txt). All retained OPEN gates remain open within their existing effects.
